The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Advisory bodies and committees
Information on the statutory advisory committees, working groups and industry consultation groups that support the work of the TGA.
-
Access Generic Medicines work-sharing initiative operational procedures update
We are advising sponsors of updates to the Generic Medicines Work-Sharing Initiative (GMWSI) operational procedures. -
TGA supports MHRA’s new international recognition framework for medicines
These international recognition routes, which have been facilitated by existing international partnerships such as those developed through the Access Consortium and Project Orbis, are part of a new international recognition framework for medicines that is specific to the UK following their exit from the European Union. -
International work-sharing - First medicines approved by all five Access Consortium regulators
TGA approves asciminib and faricimab through the Access New Active Substance Work-Sharing Initiative
-
Find out about the public submissions on scheduling matters referred to the ACMS #47 and Joint ACMS-ACCS #40 meetings held in June 2025
-
Communique from the meeting of the TGACC
-
Read the meeting statement from 13 February 2025 meeting of the Advisory Committee on Medical Devices.
-
Consultation: Proposed amendments to the Poisons Standard - ACMS and Joint ACMS-ACCS meetings - June 2025
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the
Advisory Committee on Medicines Scheduling (ACMS), or a joint meeting of the ACMS and Advisory Committee on Chemicals Scheduling (ACCS)